logo

Xoma Ltd (XOMA)



Trade XOMA now with
  Date
  Headline
9/11/2017 7:06:59 AM XOMA Corp. Says Earns $3 Mln Milestone Payment From License Deal With Nanotherapeutics
9/5/2017 10:57:12 AM Wedbush Is Increasing XOMA LTD (XOMA) 2018 Estimate To -1.82 From -1.95
9/5/2017 10:56:56 AM Wedbush Is Raising XOMA LTD (XOMA) 4Q18 Estimate To -0.35 From -0.38
9/5/2017 10:56:42 AM Wedbush Is Increasing XOMA LTD (XOMA) 3Q18 Estimate To -0.47 From -0.51
9/5/2017 10:56:29 AM Wedbush Is Increasing XOMA LTD (XOMA) 2Q18 Estimate To -0.51 From -0.55
9/5/2017 10:56:14 AM Wedbush Is Increasing XOMA LTD (XOMA) 1Q18 Estimate To -0.48 From -0.52
9/5/2017 10:55:58 AM Wedbush Is Increasing XOMA LTD (XOMA) 2017 Estimate To -2.65 From -2.75
9/5/2017 10:55:34 AM Wedbush Is Raising XOMA LTD (XOMA) 4Q17 Estimate To -0.48 From -0.51
9/5/2017 10:55:23 AM Wedbush Is Raising XOMA LTD (XOMA) 3Q17 Estimate To -0.75 From -0.80
9/5/2017 7:04:48 AM Wedbush Upgrades XOMA LTD (XOMA) To Outperform From Neutral With $19 Up From $9 Price Target
8/25/2017 7:01:49 AM XOMA Announces Transformational License Agreements For Gevokizumab And Its IL-1 Beta Intellectual Property Portfolio
5/10/2017 8:27:05 AM Wedbush Reiterates XOMA LTD (XOMA) At Neutral With $9 Price Target
5/10/2017 8:26:35 AM Wedbush Is Increasing XOMA LTD (XOMA) 2017 Estimate To -2.14 From -2.66
5/10/2017 8:26:09 AM Wedbush Is Lowering XOMA LTD (XOMA) 2017 Rev. Estimate To 13.2 M From 14.3 M